Fig. 2From: Adaptive treatment allocation and selection in multi-arm clinical trials: a Bayesian perspectivePosterior density of ρ based on Moderna, Inc. COVID-19 primary efficacy data, with posterior mode at 0.0595 and 95% HPD interval (0.030,0.105)Back to article page